Skip to main content
. 2013 Aug 1;20(1):65–72. doi: 10.1111/hae.12246

Table 1.

Subject characteristics

N (%) of Treated Subjects
All (36 subjects) On-demand (19 subjects) Prophylaxis (17 subjects)
Age
 ≥7 and <12 years 5 (13.9) 2 (10.5) 3 (17.6)
 ≥12 and <16 years 4 (11.1) 2 (10.5) 2 (11.8)
 ≥16 years of age 27 (75.0) 15 (78.9) 12 (70.6)
Race
 White 29 (80.6) 14 (73.7) 15 (88.2)
 Asian 3 (8.3) 2 (10.5) 1 (5.9)
 Black or African American 2 (5.6) 2 (10.5) 0 (0.0)
 Other 2 (5.6) 1 (5.3) 1 (5.9)
Ethnicity
 Non-hispanic or non-latino 32 (88.9) 17 (89.5) 15 (88.2)
 Hispanic or Latino 4 (11.1) 2 (10.5) 2 (11.8)
Haemophilia type
 Haemophilia A 33 (91.7) 17 (89.5) 16 (94.1)
 Haemophilia B 3 (8.3) 2 (10.5) 1 (5.9)
Severity of haemophilia
 Moderate 3 (8.3) 2 (10.5) 1 (5.9)
 Severe 33 (91.7) 17 (89.5) 16 (94.1)
Number of target joints
 0 9 (25.0) 5 (26.3) 4 (23.5)
 1 14 (38.9) 8 (42.1) 6 (35.3)
 2–3 8 (22.2) 4 (21.1) 4 (23.5)
 ≥4 5 (13.9) 2 (10.5) 3 (17.6)